Samlyn Capital’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Samlyn Capital’s Portfolio MYOK Stock Details MYOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-256,096	Closed	-$12M	–	135
2020 Q1	$12M	Buy	256,096 +40,093	+19%	+$2.57M	0.3%	65
2019 Q4	$15.7M	Sell	216,003 -119,418	-36%	-$7.24M	0.33%	68
2019 Q3	$17.5M	Buy	335,421 +77,815	+30%	+$4.14M	0.42%	64
2019 Q2	$12.9M	Buy	257,606 +37,000	+17%	+$1.8M	0.27%	87
2019 Q1	$11.5M	Sell	220,606 -63,302	-22%	-$2.92M	0.27%	76
2018 Q4	$13.9M	Buy	283,908 +182,681	+180%	+$10.1M	0.33%	76
2018 Q3	$6.6M	Sell	101,227 -144,264	-59%	-$8.48M	0.15%	106
2018 Q2	$12.2M	Buy	+245,491	New	+$11.9M	0.29%	94

Other funds holding MYOK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Samlyn Capital's MYOK Position: Q2 2020 in Review

Samlyn Capital sold out of MyoKardia, Inc. Common Stock (MYOK) in Q2 2020, closing a stake of 256,096 shares — an estimated $12M sold.

Samlyn Capital first reported a position in MYOK in Q2 2018 and held it in 8 quarters. The position peaked at $17.5M in Q3 2019. 235 funds tracked by Wall St. Rank hold MYOK as of Q2 2020.

Samlyn Capital reported no remaining MyoKardia, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
Samlyn Capital sold 256,096 MyoKardia, Inc. Common Stock shares in Q2 2020, an estimated $12M.
Samlyn Capital first reported a position in MyoKardia, Inc. Common Stock in Q2 2018 and held it in 8 quarters.
Samlyn Capital's MyoKardia, Inc. Common Stock position peaked at $17.5M in Q3 2019.
235 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q2 2020.

Based on Samlyn Capital's 13F filing for Q2 2020, filed 14 Aug 2020.